Rare diseases
Investigational molecules
Locations
Back to Spain65 clinical trials in Pontevedra, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
SpainA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
SpainStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
SpainStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
SpainStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
SpainStudy of Elafibranor for Adults with Primary Biliary Cholangitis
SpainA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
SpainPhase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo
SpainEfficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on tuberculosis treatments, including innovative approaches for both latent and active forms of the disease in special patient populations.
Research evaluating the effectiveness of various rifamycin-based regimens and high-dose antibiotic combinations.
Extensive research into liver diseases, particularly focusing on non-alcoholic steatohepatitis (NASH) and chronic hepatitis B treatments.
Multiple studies evaluating novel therapeutic approaches and combination treatments for liver conditions.
Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis and urticaria.
Investigation of new targeted therapies and dose optimization studies for various skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
